Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Globalstar (GSAT) vs Nuwellis Inc (NUWE) Price & Performance

GlobalstarTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Globalstar vs Nuwellis Inc — how do they compare? Globalstar trades at $83.51 (market cap $10.78B), while Nuwellis Inc trades at $0.7 (market cap $2.20M). The key difference: Globalstar is far larger — about 4900× Nuwellis Inc's market cap, and Globalstar is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globalstar for 20 Days and Nuwellis Inc for 26 Days on average.

GSATNUWE
Market Cap
$10.78B$2.20M
Volume
723,953121,544
Sector
MediaHealth
52-Week High
$84.43$146.65
52-Week Low
$41.54$0.68
Typical Hold Time
20 Days26 Days
Enterprise Value
$10.79B-$1.52M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Globalstar

No Aura AI signal available yet.

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GSAT
100% Buy0% Sell
Avg holding period · 20 Days
NUWE
40% Buy60% Sell
Avg holding period · 26 Days

Top news

Latest headlines on both assets

About Globalstar

Globalstar provides satellite and terrestrial connectivity services, including voice, data, asset tracking, and private wireless solutions. It operates a low-Earth-orbit satellite network and holds licensed mid-band spectrum.

Read more on GSAT →

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →